“DE-scribe” Medicines to Improve Adherence 
In this 5-minute audio snippet, Silja Chouquet, Owner at whydot GmbH, urges pharmaceutical companies to apply resources, including their brains, to come up with a solution that helps people take their medication and use these insights to develop the next generation of treatments.
Silja presented her ideas at a TEDx talk in Basel.
Your browser does not support the audio element. Upgrade your browser to one that does
In her TEDx presentation, which is embedded below, Silja places most of the blame for non-adherence on patient lifestyles:
Meanwhile, a whopping 93% of physicians feel that “worry about side effects” was a moderate or significant reason for non-adherence (see here), which suggests that to improve adherence, drug companies should change THEIR behavior – such as focusing more on creating drugs with fewer side effects.
